Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 260.22B, Merck(MRK) trades at $104.62. The stock has a price-to-earnings ratio of 13.87 and currently yields dividends of 3.1%.
As of 2025-11-30, Merck(MRK) stock has fluctuated between $104.12 and $105.41. The current price stands at $104.62, placing the stock +0.5% above today's low and -0.7% off the high.
The Merck(MRK)'s current trading volume is 6.15M, compared to an average daily volume of 18.18M.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $105.84 at its peak.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $105.84 at its peak.
MRK News
If you are thinking in decades and not days, this trio of dividend stocks could be the perfect starting point for your fledgling portfolio. If investing were e...
Merck (MRK) shares have picked up some steam this week, trading higher over the past month. Investors are taking note as the company maintains a steady growth p...
Key Points One of Merck's key assets has just scored a significant phase 2 win, boosting investor confidence. This adds to other recent developments that coul...
Analyst ratings
55%
of 29 ratingsMore MRK News
Bristol Myers BMY has a robust oncology portfolio, including the blockbuster immune-oncology drugs, Opdivo, Opdivo Qvantig and Yervoy, among others. Opdivo is...
AstraZeneca AZN and Merck MRK are both major global pharmaceutical companies with diversified drug portfolios. While Merck is a U.S.-based company, AstraZeneca’...
Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influenc...
In recent trading, shares of Merck & Co Inc (Symbol: MRK) have crossed above the average analyst 12-month target price of $92.07, changing hands for $92.32/shar...
Merck received FDA approval for Keytruda (including the new subcutaneous Keytruda QLEX) in combination with Padcev for use before and after surgery in adults wi...
Merck (MRK) announced that new data across multiple hematologic malignancies will be presented at the American Society of Hematology Annual Meeting and Expositi...
Wells Fargo upgraded Merck (MRK) to Overweight from Equal Weight with a price target of $125, up from $90. Following recent business development, pipeline progr...